BP’s Edwards Lifesciences EW Stock Holding History

BP’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-141,312	Closed	-$14.6M	–	191
2021 Q2	$14.6M	Sell	141,312 -40,315	-22%	-$3.8M	0.63%	49
2021 Q1	$15.2M	Sell	181,627 -22,229	-11%	-$1.88M	0.53%	66
2020 Q4	$18.6M	Sell	203,856 -24,199	-11%	-$2.01M	0.56%	61
2020 Q3	$18.2M	Buy	228,055 +164,755	+260%	+$12.9M	0.44%	57
2020 Q2	$4.37M	Hold	63,300	–	–	0.16%	145
2020 Q1	$3.98M	Hold	63,300	–	–	0.17%	138
2019 Q4	$4.92M	Hold	63,300	–	–	0.17%	141
2019 Q3	$4.64M	Buy	63,300 +1,500	+2%	+$105K	0.17%	147
2019 Q2	$3.81M	Buy	+61,800	New	+$3.74M	0.14%	167
2019 Q1	–	Sell	-81,000	Closed	-$4.14M	–	406
2018 Q4	$4.14M	Hold	81,000	–	–	0.17%	147
2018 Q3	$4.7M	Hold	81,000	–	–	0.14%	170
2018 Q2	$3.93M	Buy	81,000 +6,000	+8%	+$280K	0.13%	196
2018 Q1	$3.49M	Hold	75,000	–	–	0.13%	206
2017 Q4	$2.82M	Hold	75,000	–	–	0.1%	242
2017 Q3	$2.73M	Sell	75,000 -66,000	-47%	-$2.52M	0.1%	251
2017 Q2	$5.56M	Buy	141,000 +66,000	+88%	+$2.41M	0.2%	142
2017 Q1	$2.35M	Buy	75,000 +33,000	+79%	+$1.03M	0.09%	266
2016 Q4	$1.31M	Sell	42,000 -108,000	-72%	-$3.5M	0.05%	369
2016 Q3	$6.03M	Hold	150,000	–	–	0.23%	124
2016 Q2	$4.99M	Buy	150,000 +27,000	+22%	+$924K	0.2%	147
2016 Q1	$3.62M	Buy	123,000 +39,000	+46%	+$1.08M	0.15%	183
2015 Q4	$2.21M	Hold	84,000	–	–	0.09%	244
2015 Q3	$1.99M	Buy	+84,000	New	+$2.03M	0.09%	237
2015 Q1	–	Sell	-102,000	Closed	-$2.16M	–	303
2014 Q4	$2.16M	Buy	102,000 +18,000	+21%	+$362K	0.06%	271
2014 Q3	$1.43M	Buy	+84,000	New	+$1.33M	0.04%	281

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BP's EW Position: Q3 2021 in Review

BP sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 141,312 shares — an estimated $14.6M sold.

BP first reported a position in EW in Q3 2014 and held it in 25 quarters. The position peaked at $18.6M in Q4 2020. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

BP reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
BP sold 141,312 Edwards Lifesciences shares in Q3 2021, an estimated $14.6M.
BP first reported a position in Edwards Lifesciences in Q3 2014 and held it in 25 quarters.
BP's Edwards Lifesciences position peaked at $18.6M in Q4 2020.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.